Henry James International Management’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-34,355
Closed -$433K 150
2021
Q3
$433K Sell
34,355
-3,265
-9% -$45.2K 0.14% 112
2021
Q2
$582K Buy
37,620
+25
+0.1% +$420 0.17% 105
2021
Q1
$760K Buy
+37,595
New +$930K 0.23% 92
2019
Q2
Sell
-18,696
Closed -$343K 140
2019
Q1
$343K Sell
18,696
-16,920
-48% -$300K 0.16% 123
2018
Q4
$593K Buy
35,616
+84
+0.2% +$1.95K 0.38% 74
2018
Q3
$1M Buy
+35,532
New +$1.02M 0.38% 87

Other funds holding CLLS

Henry James International Management's CLLS Position: Q4 2021 in Review

Henry James International Management sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 34,355 shares — an estimated $433K sold.

Henry James International Management first reported a position in CLLS in Q3 2018 and held it in 6 quarters. The position peaked at $1M in Q3 2018. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Henry James International Management reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Henry James International Management sold 34,355 Cellectis shares in Q4 2021, an estimated $433K.
  • Henry James International Management first reported a position in Cellectis in Q3 2018 and held it in 6 quarters.
  • Henry James International Management's Cellectis position peaked at $1M in Q3 2018.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Henry James International Management's 13F filing for Q4 2021, filed 18 Jan 2022.